The weight-loss conversation is moving beyond willpower

Weight loss has long been sold as a test of willpower: eat differently, move more, try harder. The visibility of GLP-1 medicines is unsettling that script by making medical treatment part of a conversation once framed almost entirely as personal discipline.

For many people, the change carries emotional weight as well as clinical meaning. A body, a prescription and a decision about care can become public symbols of effort, responsibility or failure, even when none of those labels captures a person’s circumstances.

That shift in language does not end stigma, settle who should use a medicine or make access equal. It marks a cultural transition: the old explanation is losing its monopoly, while the more humane replacement is still being worked out.

Read the full story at Vox ↗